Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation (DNA Extraction, Library Preparation), Instruments) Type (SMRT, DNB) Application (Clinical, Research) End User – Forecast to 2031
Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation (DNA Extraction, Library Preparation), Instruments) Type (SMRT, DNB) Application (Clinical, Research) End User–Forecast to 2031
Saudi Arabia NGS market is projected to reach $ 50.0 million by 2031 at a CAGR of 10.1% during the forecast period from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the rising number of cancer cases, increasing pharmaceutical R&D expenditures, and the surge in genome mapping programs are factors driving the growth of Saudi Arabia NGS market. However, the high costs of NGS systems and consumables, data confidentiality concerns, the availability of alternative technologies, the low chances of identifying positive, actionable biomarkers, and ethical & legal issues related to NGS-based diagnosis restrain the growth of this market
In addition, the increasing adoption of NGS tools among hospitals and clinical laboratories and government initiatives supporting large-scale genomic sequencing projects offer considerable growth opportunities for market players. However, the shortage of skilled professionals, issues related to data storage, handling, interpretation, and confidentiality, and concerns about regulatory standards and standardization in diagnostic testing are some of the challenges impacting the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years (2020–2024). Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).
Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 10.3% during the forecast period. This segment's growth is attributed to the increasing prevalence of genetic diseases, growing adoption of genetic testing, and recurring purchases of consumables over instruments.
Among all the sequencing types studied in this report, the targeted genome sequencing segment is slated to register the highest growth rate of 11.2% during the forecast period. This technology has facilitated the study of gene-drug associations, aiding in the design of gene-specific drugs with higher precision, thus increasingly adopted by pharmaceutical and biotechnology companies. Additionally, low cost, improved accuracy and speed, and greater depth of coverage than other sequencing methods are further driving the market growth.
Among all the applications studied in this report, in 2024, the research & other applications segment is expected to account for the largest share of 56.9% of Saudi Arabia NGS market. The large share of the segment is attributed to the rising prevalence of genetic diseases, the increasing need for pathogen surveillance, the availability of funding for agriculture and animal research, and supportive government initiatives. For instance, under Vision 2030, $10 billion was allocated to stabilize the global food supply chain and boost domestic agricultural production.
Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to record the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to the increasing R&D expenditure by pharmaceutical & biotechnology companies, the rising utilization of genomics for research processes, and an increasing number of biotechnology companies. Moreover, the National Biotechnology Strategy by the Saudi Arabian government is aimed at localizing bio-manufacturing, driving market growth.
Scope of the Report:
Saudi Arabia NGS Market—by Offering
Saudi Arabia NGS Market—by Sequencing Type
sequencing, and methylation sequencing.
Saudi Arabia NGS Market—by Applications
Other clinical applications include the detection of metabolic and immune disorders and foodborne illnesses.
.
Saudi Arabia NGS Market—by End User
Saudi Arabia NGS market is projected to reach $ 50.0 million by 2031 at a CAGR of 10.1% during the forecast period from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the rising number of cancer cases, increasing pharmaceutical R&D expenditures, and the surge in genome mapping programs are factors driving the growth of Saudi Arabia NGS market. However, the high costs of NGS systems and consumables, data confidentiality concerns, the availability of alternative technologies, the low chances of identifying positive, actionable biomarkers, and ethical & legal issues related to NGS-based diagnosis restrain the growth of this market
In addition, the increasing adoption of NGS tools among hospitals and clinical laboratories and government initiatives supporting large-scale genomic sequencing projects offer considerable growth opportunities for market players. However, the shortage of skilled professionals, issues related to data storage, handling, interpretation, and confidentiality, and concerns about regulatory standards and standardization in diagnostic testing are some of the challenges impacting the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years (2020–2024). Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).
Among all the offerings studied in this report, the consumables segment is projected to register the highest CAGR of 10.3% during the forecast period. This segment's growth is attributed to the increasing prevalence of genetic diseases, growing adoption of genetic testing, and recurring purchases of consumables over instruments.
Among all the sequencing types studied in this report, the targeted genome sequencing segment is slated to register the highest growth rate of 11.2% during the forecast period. This technology has facilitated the study of gene-drug associations, aiding in the design of gene-specific drugs with higher precision, thus increasingly adopted by pharmaceutical and biotechnology companies. Additionally, low cost, improved accuracy and speed, and greater depth of coverage than other sequencing methods are further driving the market growth.
Among all the applications studied in this report, in 2024, the research & other applications segment is expected to account for the largest share of 56.9% of Saudi Arabia NGS market. The large share of the segment is attributed to the rising prevalence of genetic diseases, the increasing need for pathogen surveillance, the availability of funding for agriculture and animal research, and supportive government initiatives. For instance, under Vision 2030, $10 billion was allocated to stabilize the global food supply chain and boost domestic agricultural production.
Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to record the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to the increasing R&D expenditure by pharmaceutical & biotechnology companies, the rising utilization of genomics for research processes, and an increasing number of biotechnology companies. Moreover, the National Biotechnology Strategy by the Saudi Arabian government is aimed at localizing bio-manufacturing, driving market growth.
Scope of the Report:
Saudi Arabia NGS Market—by Offering
- Consumables
- Sample Preparation Consumables
- Library Preparation & Target Enrichment
- DNA Extraction and Amplification
- Quality Control
- Other Kits & Reagents
- Sequencing Consumables
- NGS Platform/Instruments
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- DNA Nanoball (DNB) Sequencing
- Single-molecule Real-time Sequencing & Nanopore Sequencing
- Software
- Services
Saudi Arabia NGS Market—by Sequencing Type
- Targeted Genome Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Other Sequencing Types
sequencing, and methylation sequencing.
Saudi Arabia NGS Market—by Applications
- Research & Other Applications
- Cancer Research
- Agriculture & Animal Research
- Microbiology & Infectious Disease Research
- Genetic Diseases Research
- Cell & Molecular Biology Research
- Other Applications
- Clinical Applications
- Oncology
- Reproductive Health
- Infectious Disease
- Genetic Disorders
- Other Clinical Applications
Other clinical applications include the detection of metabolic and immune disorders and foodborne illnesses.
.
Saudi Arabia NGS Market—by End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Academic Institutes & Research Centers
- Other End Users
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency & Limitation
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Approach
2.2. Process Of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Market Share Analysis
2.3.3. Growth Forecast Approach
2.4. Assumptions For the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research Driving Market Growth
4.2.1.2. Availability of Alternative Technologies Restraining Market Growth
4.2.1.3. Increasing Application of NGS In Personalized Medicine Generating Growth Opportunities for Market Players
4.2.1.4. Data Storage, Handling, Interpretation, and Confidentiality Concerns Expected to Remain a Major Challenge for Market Stakeholders
4.2.2. Macroindicators
4.3. Industry Trends
4.3.1. Development of Portable Sequencing Technologies
4.3.2. Increasing Demand for NGS Automation
4.4. Regulatory Analysis
4.5. Health Sector Scenario
4.5.1. Overview
4.5.2. Key Health Indicators
4.5.3. Major Stakeholders
4.5.4. Initiatives/Programs to Improve Healthcare Sector in Saudi Arabia
4.5.4.1. Saudi Vision 2030
4.5.4.2. National Biotech Strategy
4.5.4.3. Saudi Genome Program
4.5.4.4. Healthcare Sector Transformation Program
4.5.4.5. Saudi Biobank Project
4.5.4.6. Saudi Arabia: Regional Headquarters Program (RHQ)
4.5.4.7. Other Large-Scale Initiatives
4.6. IVD Industry Landscape
4.7. Reimbursement Scenario
5. SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET ASSESSMENT—BY OFFERING
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Consumables
5.2.1.1. Library Preparation & Target Enrichment
5.2.1.2. DNA Extraction and Amplification
5.2.1.3. Quality Control
5.2.1.4. Other Kits & Reagents
5.2.2. Sequencing Consumables
5.3. NGS Platforms/Instruments
5.3.1. Sequencing By Synthesis
5.3.2. Ion Semiconductor Sequencing
5.3.3. DNA Nanoball (DNB) Sequencing
5.3.4. Single-Molecule Real-Time Sequencing & Nanopore Sequencing
5.4. Software
5.5. Services
6. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY SEQUENCING TYPE
6.1. Overview
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types
7. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY APPLICATION
7.1. Overview
7.2. Research & Other Applications
7.2.1. Cancer Research
7.2.2. Agriculture & Animal Research
7.2.3. Microbiology & Infectious Disease Research
7.2.4. Genetic Diseases Research
7.2.5. Cell & Molecular Biology Research
7.2.6. Other Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Genetic Disorders
7.3.5. Other Clinical Applications
8. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY END USER
8.1. Overview
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Centers
8.5. Other End Users
9. COMPETITION ANALYSIS
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis
9.5.1. Illumina, Inc. (U.S.)
9.5.2. F. Hoffmann-La Roche Ltd. (Switzerland)
9.5.3. Beijing Genomics Institute (BGI) (China)
10. COMPANY PROFILES
10.1. Illumina, Inc.
10.2. Thermo Fisher Scientific Inc.
10.3. F. Hoffmann-La Roche Ltd
10.4. Beijing Genomics Institute (BGI)
10.5. Pacific Biosciences of California Inc.
10.6. Qiagen N.V.
10.7. Agilent Technologies, Inc.
10.8. Revvity, Inc.
10.9. Danaher Corporation
10.10. Oxford Nanopore Technologies Plc.
10.11. Bio-Rad Laboratories, Inc.
10.12. 10x Genomics, Inc.
Table 1 Saudi Arabia NGS Market: Impact Analysis of Market Dynamics (2024–2031)
Table 2 Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 3 Portable Sequencers Vs. Benchtop Sequencers
Table 4 Number of Physicians in Saudi Arabia, 2016-2021 (Per 1000 People)
Table 5 Number of Hospital Beds in Key Government Hospitals
Table 6 Recent Developments
Table 7 Saudi Arabia: Number of Healthcare Providers, by Sector (2023)
Table 8 Saudi Arabia: Healthcare Infrastructure, by Healthcare Provider Type (2023)
Table 9 Prevalence of Common Chronic Diseases in Saudi Arabia Vs. Global (%)
Table 10 Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 11 Saudi Arabia: Diabetes Prevalence, 2011 Vs. 2021 Vs. 2030 Vs. 2045
Table 12 Key Government Stakeholders
Table 13 Other Stakeholders
Table 14 Major Focus Areas of Vision 2030 Policy
Table 15 Major Focus Areas of National Biotech Strategy
Table 16 Developments in Saudi Arabia's Regional Headquarters Program
Table 17 Mandatory and Optional Activities for RHQ'S
Table 18 Saudi Arabia NGS Market, by Offering, 2022–2031 (USD Million)
Table 19 Saudi Arabia NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 20 Saudi Arabia NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 21 Saudi Arabia NGS Platforms/Instruments Market, by Technology, 2022-2031 (USD Million)
Table 22 Major Applications of Ion Torrent Sequencing
Table 23 Saudi Arabia NGS Market, by Sequencing Type, 2022-2031 (USD Million)
Table 24 Saudi Arabia NGS Market, by Application, 2022-2031 (USD Million)
Table 25 Saudi Arabia NGS Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 26 Saudi Arabia NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 27 Currently Available Targeted Therapies and Corresponding Biomarkers
Table 28 Saudi Arabia Next-Generation Sequencing Market, by End User, 2022–2031 (USD Million)
Table 29 Recent Developments, by Company, 2021-2024
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency & Limitation
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Approach
2.2. Process Of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Market Share Analysis
2.3.3. Growth Forecast Approach
2.4. Assumptions For the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research Driving Market Growth
4.2.1.2. Availability of Alternative Technologies Restraining Market Growth
4.2.1.3. Increasing Application of NGS In Personalized Medicine Generating Growth Opportunities for Market Players
4.2.1.4. Data Storage, Handling, Interpretation, and Confidentiality Concerns Expected to Remain a Major Challenge for Market Stakeholders
4.2.2. Macroindicators
4.3. Industry Trends
4.3.1. Development of Portable Sequencing Technologies
4.3.2. Increasing Demand for NGS Automation
4.4. Regulatory Analysis
4.5. Health Sector Scenario
4.5.1. Overview
4.5.2. Key Health Indicators
4.5.3. Major Stakeholders
4.5.4. Initiatives/Programs to Improve Healthcare Sector in Saudi Arabia
4.5.4.1. Saudi Vision 2030
4.5.4.2. National Biotech Strategy
4.5.4.3. Saudi Genome Program
4.5.4.4. Healthcare Sector Transformation Program
4.5.4.5. Saudi Biobank Project
4.5.4.6. Saudi Arabia: Regional Headquarters Program (RHQ)
4.5.4.7. Other Large-Scale Initiatives
4.6. IVD Industry Landscape
4.7. Reimbursement Scenario
5. SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET ASSESSMENT—BY OFFERING
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Consumables
5.2.1.1. Library Preparation & Target Enrichment
5.2.1.2. DNA Extraction and Amplification
5.2.1.3. Quality Control
5.2.1.4. Other Kits & Reagents
5.2.2. Sequencing Consumables
5.3. NGS Platforms/Instruments
5.3.1. Sequencing By Synthesis
5.3.2. Ion Semiconductor Sequencing
5.3.3. DNA Nanoball (DNB) Sequencing
5.3.4. Single-Molecule Real-Time Sequencing & Nanopore Sequencing
5.4. Software
5.5. Services
6. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY SEQUENCING TYPE
6.1. Overview
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types
7. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY APPLICATION
7.1. Overview
7.2. Research & Other Applications
7.2.1. Cancer Research
7.2.2. Agriculture & Animal Research
7.2.3. Microbiology & Infectious Disease Research
7.2.4. Genetic Diseases Research
7.2.5. Cell & Molecular Biology Research
7.2.6. Other Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Genetic Disorders
7.3.5. Other Clinical Applications
8. SAUDI ARABIA NEXT-GENERATION SEQUENCING MARKET ASSESSMENT—BY END USER
8.1. Overview
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Centers
8.5. Other End Users
9. COMPETITION ANALYSIS
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis
9.5.1. Illumina, Inc. (U.S.)
9.5.2. F. Hoffmann-La Roche Ltd. (Switzerland)
9.5.3. Beijing Genomics Institute (BGI) (China)
10. COMPANY PROFILES
10.1. Illumina, Inc.
10.2. Thermo Fisher Scientific Inc.
10.3. F. Hoffmann-La Roche Ltd
10.4. Beijing Genomics Institute (BGI)
10.5. Pacific Biosciences of California Inc.
10.6. Qiagen N.V.
10.7. Agilent Technologies, Inc.
10.8. Revvity, Inc.
10.9. Danaher Corporation
10.10. Oxford Nanopore Technologies Plc.
10.11. Bio-Rad Laboratories, Inc.
10.12. 10x Genomics, Inc.
Table 1 Saudi Arabia NGS Market: Impact Analysis of Market Dynamics (2024–2031)
Table 2 Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 3 Portable Sequencers Vs. Benchtop Sequencers
Table 4 Number of Physicians in Saudi Arabia, 2016-2021 (Per 1000 People)
Table 5 Number of Hospital Beds in Key Government Hospitals
Table 6 Recent Developments
Table 7 Saudi Arabia: Number of Healthcare Providers, by Sector (2023)
Table 8 Saudi Arabia: Healthcare Infrastructure, by Healthcare Provider Type (2023)
Table 9 Prevalence of Common Chronic Diseases in Saudi Arabia Vs. Global (%)
Table 10 Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 11 Saudi Arabia: Diabetes Prevalence, 2011 Vs. 2021 Vs. 2030 Vs. 2045
Table 12 Key Government Stakeholders
Table 13 Other Stakeholders
Table 14 Major Focus Areas of Vision 2030 Policy
Table 15 Major Focus Areas of National Biotech Strategy
Table 16 Developments in Saudi Arabia's Regional Headquarters Program
Table 17 Mandatory and Optional Activities for RHQ'S
Table 18 Saudi Arabia NGS Market, by Offering, 2022–2031 (USD Million)
Table 19 Saudi Arabia NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 20 Saudi Arabia NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 21 Saudi Arabia NGS Platforms/Instruments Market, by Technology, 2022-2031 (USD Million)
Table 22 Major Applications of Ion Torrent Sequencing
Table 23 Saudi Arabia NGS Market, by Sequencing Type, 2022-2031 (USD Million)
Table 24 Saudi Arabia NGS Market, by Application, 2022-2031 (USD Million)
Table 25 Saudi Arabia NGS Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 26 Saudi Arabia NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 27 Currently Available Targeted Therapies and Corresponding Biomarkers
Table 28 Saudi Arabia Next-Generation Sequencing Market, by End User, 2022–2031 (USD Million)
Table 29 Recent Developments, by Company, 2021-2024
